Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative Study
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
To explore the meaning, causes and treatment of hypertension in eligible patients. In addition the cultural, social, and psychological factors that either facilitate or serve, as barriers to behavioral change will be illuminated in this patient population.
Condition or disease
Behavioral: Semi-structured, open ended interview
The first goal is to explore the meaning, causes and treatment of hypertension in eligible patients. In addition the cultural, social, and psychological factors that either facilitate or serve, as barriers to behavioral change will be illuminated in this patient population. Through a series of open-ended questions we will explore and build a better understanding of how hypertensive African American patients view their illness and the difficulties they have in taking their antihypertensive medications as prescribed.
The second goal of the qualitative phase is to use the responses obtained to inform how we should operationalize and tailor the positive affect induction and self-affirmation intervention methods in hypertensive African American patients.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients must be self-identified as African-Americans.
All patients must be aged 18 years and older.
All patients must be diagnosed as having hypertension: For this project, hypertension will be defined according to the widely accepted criteria of the 6th Joint National Committee (JNC VI) Guidelines on Prevention, Detection, Evaluation and Treatment of Hypertension, which is a systolic blood pressure > 140 mm hg or a diastolic blood pressure > 90 mm hg or if participants are taking any prescribed antihypertensive medication.
Patients must be able to provide informed consent in English.
Patients who refuse to participate
Patients who are unable to provide informed consent.
Factors That Influence Medication Adherence Among African-Americans With Hypertension. Moore, JA, Boutin-Foster, C, Charlson, ME. Weill Medical College of Cornell University, New York, NY. Presented at the 12th Annual NHLBI Cardiovascular Minority Research Supplement Awardee Session, American Heart Association, November 2004.
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):